Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2018 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Invitation to third quarter 2018 presentation

Oslo, Norway, 06 November 2018 - PCI Biotech invites to a presentation of the company's third quarter 2018 report on Tuesday 13 November 2018 at Oslo Cancer Cluster Innovation Park. Time: Tuesday...
October 24, 2018 05:01 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Capital increase registered and listing of new shares

Oslo, Norway, 24 October 2018. Reference is made to the previous announcements by PCI Biotech Holding ASA ("PCI Biotech" or the "Company") in respect of the issuance of 170,000 new shares following...
October 19, 2018 04:03 ET | Source: PCI Biotech Holding ASA

PCI Biotech to present Phase I dose escalation results at ESMO

Oslo, Norway, 19 October 2018 — PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the company will present results from the Phase I dose escalation study in...
October 17, 2018 12:48 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Exercise of employee share options, mandatory noticifation of trade and resolution to increase share capital

Oslo (Norway), 17 October 2018 – Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital in PCI Biotech Holding ASA (the “Company”). 1. ...
October 10, 2018 08:21 ET | Source: PCI Biotech Holding ASA

Disclosure of large shareholding

Bergen, 10 October 2018 – reference is made to the previous announcement on 24 September 2018 regarding the disclosure of large shareholdings in relation to the rights issue in PCI Biotech Holding ASA...
October 10, 2018 03:20 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Capital increase registered and listing of new shares

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR...
October 04, 2018 06:44 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Final results of the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR...
October 03, 2018 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Last day of subscription period

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR...
September 28, 2018 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Last day of trading in subscription rights Monday 01 October 2018

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR...
September 24, 2018 13:38 ET | Source: PCI Biotech Holding ASA

Disclosure of large shareholdings

Bergen, 24 September 2018 - Myrlid AS, a company controlled by Kjetil Myrlid Aasen, has today, purchased 129,800 subscription rights in PCI Biotech Holding ASA's (“PCI Biotech”) ongoing rights issue....